Economic evaluation of apixaban for the prevention of stroke in non-valvular atrial fibrillation in the Netherlands.

<h4>Background</h4>Stroke prevention is the main goal of treating patients with atrial fibrillation (AF). Vitamin-K antagonists (VKAs) present an effective treatment in stroke prevention, however, the risk of bleeding and the requirement for regular coagulation monitoring are limiting th...

Full description

Saved in:
Bibliographic Details
Main Authors: Jelena Stevanović, Marjolein Pompen, Hoa H Le, Mark H Rozenbaum, Robert G Tieleman, Maarten J Postma
Format: article
Language:EN
Published: Public Library of Science (PLoS) 2014
Subjects:
R
Q
Online Access:https://doaj.org/article/66a2246e4ad8431898941e600348e958
Tags: Add Tag
No Tags, Be the first to tag this record!